Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Morris

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Science Advances|February 22, 2023
Biomineralogical signatures of breast microcalcificationsJennie A M R Kunitake, Daniel Sudilovsky, Lynn M Johnson, et al.
Cancer Medicine|November 23, 2019
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastomaJack Patrick Gleeson, Fergus Keane, Niamh M Keegan, et al.
Cancer|April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerPatrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2015
Menopause is a determinant of breast adipose inflammationNeil M Iyengar, Patrick G Morris, Xi Kathy Zhou, et al.
JAMA Dermatology|February 7, 2019
Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney TransplantsDonal J Sexton, Patrick O'Kelly, Eamonn O'Leary, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
BMC Cancer|January 17, 2024
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)Gavin P Dowling, Sinead Toomey, Philip Bredin, et al.
Cancer|January 23, 2014
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongueNeil M Iyengar, Amit Kochhar, Patrick G Morris, et al.
Cancer Treatment and Research Communications|April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancerAoife Carr, Jonathan A Coulter, Julie Workman, et al.
Irish Journal of Medical Science|May 12, 2021
Delivery of systemic anti-cancer therapy during the COVID-19 pandemicOrla Fitzpatrick, Roisin Ní Dhonaill, Anna Linehan, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Science Advances|February 22, 2023
Biomineralogical signatures of breast microcalcificationsJennie A M R Kunitake, Daniel Sudilovsky, Lynn M Johnson, et al.
Cancer Medicine|November 23, 2019
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastomaJack Patrick Gleeson, Fergus Keane, Niamh M Keegan, et al.
Cancer|April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerPatrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2015
Menopause is a determinant of breast adipose inflammationNeil M Iyengar, Patrick G Morris, Xi Kathy Zhou, et al.
JAMA Dermatology|February 7, 2019
Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney TransplantsDonal J Sexton, Patrick O'Kelly, Eamonn O'Leary, et al.
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.
BMC Cancer|January 17, 2024
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)Gavin P Dowling, Sinead Toomey, Philip Bredin, et al.
Cancer|January 23, 2014
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongueNeil M Iyengar, Amit Kochhar, Patrick G Morris, et al.
Cancer Treatment and Research Communications|April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancerAoife Carr, Jonathan A Coulter, Julie Workman, et al.
Irish Journal of Medical Science|May 12, 2021
Delivery of systemic anti-cancer therapy during the COVID-19 pandemicOrla Fitzpatrick, Roisin Ní Dhonaill, Anna Linehan, et al.
Pageof 10